Viewing nowSpitin Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.35mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 200807683 · Notified 2008.07.10 · Insurance code 641602890
Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication helps reduce the risk of cardiovascular diseases. It particularly decreases the risk of myocardial infarction, stroke, vascular procedures, hospitalization due to congestive heart failure, angina, and various cardiovascular diseases. It lowers total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels in patients with hyperlipidemia while increasing HDL-cholesterol levels to improve blood lipid status. It is effectively used to manage cholesterol levels in patients with familial hypercholesterolemia, especially in children and adolescents aged 10 to 17 years who find it difficult to control with diet alone. Overall, this drug helps manage several risk factors for cardiovascular diseases and improve dyslipidemia to maintain cardiovascular health. Therefore, it is used for reducing the risk of cardiovascular disease and treating hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate for each patient according to the recommended treatment goals. The dose should be adjusted at intervals of 4 weeks or longer.
This medication should be discontinued immediately and a doctor consulted if any unusual symptoms occur in the muscles. There is a risk of developing serious muscle diseases such as myopathy or rhabdomyolysis, so caution is needed, especially for patients with renal or liver function issues. It should not be used by those allergic to this medication or who have liver or muscle diseases, by pregnant or breastfeeding women, children under 10 years of age, or patients taking certain medications. Patients with a history of alcoholism or liver disease, hypothyroidism, and the elderly should be more cautious and report any muscle-related symptoms to healthcare providers immediately. Regular liver function tests and blood tests should be performed while on this medication, and if symptoms of hepatitis, muscle pain, fatigue, or fever occur, consult a doctor immediately. Co-administration with certain antibiotics, antifungals, antivirals, etc., may increase the blood concentration of this medication, raising the risk of side effects, so inform healthcare providers about all medications taken. Women of childbearing age taking this medication should use appropriate contraception and discontinue the medication immediately if pregnancy is confirmed. Breastfeeding women should not take this medication, and children and the elderly should be carefully observed due to the potential for side effects.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.35mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.